MedX Health Corp (CVE:MDX – Get Free Report) hit a new 52-week high on Thursday . The company traded as high as C$0.10 and last traded at C$0.10, with a volume of 41500 shares. The stock had previously closed at C$0.09.
MedX Health Price Performance
The firm has a market cap of C$23.58 million, a P/E ratio of -3.00 and a beta of 1.21. The business’s 50 day moving average is C$0.06 and its two-hundred day moving average is C$0.06.
MedX Health (CVE:MDX – Get Free Report) last posted its quarterly earnings results on Wednesday, March 6th. The company reported C($0.53) EPS for the quarter. The business had revenue of C$26.41 million for the quarter. Equities research analysts anticipate that MedX Health Corp will post 0.0029191 EPS for the current year.
About MedX Health
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market.
Featured Articles
- Five stocks we like better than MedX Health
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Hasbro’s Management Made All the Right Calls This Quarter
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
